Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.

MLA

Polano, Maurizio, et al. “Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.” Clinical Pharmacology and Therapeutics, vol. 114, no. 3, Sept. 2023, pp. 652–63. EBSCOhost, https://doi.org/10.1002/cpt.2960.

APA

Polano, M., Bedon, L., Dal Bo, M., Sorio, R., Bartoletti, M., De Mattia, E., Cecchin, E., Pisano, C., Lorusso, D., Lissoni, A. A., De Censi, A., Cecere, S. C., Scollo, P., Marchini, S., Arenare, L., De Giorgi, U., Califano, D., Biagioli, E., Chiodini, P., … Toffoli, G. (2023). Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab. Clinical Pharmacology and Therapeutics, 114(3), 652–663. https://doi.org/10.1002/cpt.2960

Chicago

Polano, Maurizio, Luca Bedon, Michele Dal Bo, Roberto Sorio, Michele Bartoletti, Elena De Mattia, Erika Cecchin, et al. 2023. “Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.” Clinical Pharmacology and Therapeutics 114 (3): 652–63. doi:10.1002/cpt.2960.